A Study of CDX-622 in Participants With Mild to Moderate Asthma

Clinical trial NCT07330778 · RECRUITING

Trial details

NCT number: NCT07330778
Sponsor: Celldex Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mild to Moderate Asthma

Start date: 2026-06-01
Primary completion: 2027-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.